Skip to content
Colorectal Cancer Clinical Trials

Orlando, Florida

Colorectal cancer clinical trials in Orlando, FL

23 colorectal cancer studies are recruiting participants at sites in Orlando as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Orlando at a glance

  • 23 studies are recruiting at a site in Orlando.
  • By phase: Phase 1 (4), Phase 1/2 (4), Phase 2 (3), Phase 2/3 (1), Phase 3 (6), No phase (5). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (19), university, hospital or other (4).
  • Most recent update to one of these records: November 13, 2026.

Studies recruiting in Orlando

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses

    • No phase
    • Ages 22 and older
    • All sexes
    Sponsor
    GI Windows, Inc.
    Study site
    Orlando Health
    Registry record
    NCT07276529 · updated
  2. A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Orlando Health Cancer Institute ( Site 0065)
    Registry record
    NCT06997497 · updated
  3. Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Study site
    Orlando Health Cancer Institute
    Registry record
    NCT07750158 · updated
  4. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Registry record
    NCT07228832 · updated
  5. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    AdventHealth East Orlando · AdventHealth Orlando · Orlando Health Cancer Institute
    Registry record
    NCT05174169 · updated
  6. A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    AdventHealth Medical Group Oncology and Hematology at Orlando
    Registry record
    NCT06662786 · updated
  7. A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    AdventHealth Cancer Institute
    Registry record
    NCT06750094 · updated
  8. A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Study site
    Sarah Cannon Research Institute (Lake Nona)
    Registry record
    NCT03526835 · updated
  9. A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    AdventHealth Orlando /ID# 270789
    Registry record
    NCT06820463 · updated
  10. A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Alterome Therapeutics, Inc.
    Registry record
    NCT06835569 · updated
  11. Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Sutro Biopharma, Inc.
    Study site
    SCRI at Florida Cancer Specialists
    Registry record
    NCT07807345 · updated
  12. Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population

    • No phase
    • Ages 45 to 84
    • All sexes
    Sponsor
    Jubaan Ltd.
    Study site
    Orlando Gastroenterology, PA
    Registry record
    NCT07623902 · updated
  13. A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Criterium, Inc.
    Study site
    Orlando Health Cancer Institute
    Registry record
    NCT06992258 · updated
  14. A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    Florida Cancer Specialists
    Registry record
    NCT07186842 · updated
  15. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    PMV Pharmaceuticals, Inc
    Study site
    Advent Health
    Registry record
    NCT04585750 · updated
  16. A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Aktis Oncology, Inc.
    Study site
    Advent Health Medical Group Radiation Oncology at Central Florida
    Registry record
    NCT07020117 · updated
  17. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Study sites
    Florida Cancer Specialists · Sarah Cannon Research Institute at Florida Cancer Specialists
    Registry record
    NCT06131840 · updated
  18. A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Ono Pharmaceutical Co., Ltd.
    Study site
    Advent Health
    Registry record
    NCT06948448 · updated
  19. Increasing Germline Genetic Testing for Patients With Cancer

    • No phase
    • All ages
    • All sexes
    Sponsor
    Josh Peterson
    Study site
    Orlando VA Medical Center
    Registry record
    NCT07307664 · updated
  20. Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Rapamycin Holdings Inc.
    Study site
    Digestive & Liver Center of Florida
    Registry record
    NCT06950385 · updated
  21. Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Tasca Therapeutics
    Study site
    Florida Cancer Specialists-Lake Nona
    Registry record
    NCT07030257 · updated
  22. Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    AdventHealth Translational Research Institute
    Study site
    AdventHealth
    Registry record
    NCT05773144 · updated
  23. Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    AdventHealth Translational Research Institute
    Study site
    AdventHealth
    Registry record
    NCT05789433 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Orlando, FL on ClinicalTrials.gov.

Ask about studies near Orlando

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call